NL8503597A - METHOD FOR IDENTIFYING NUCLEIC ACIDS. - Google Patents
METHOD FOR IDENTIFYING NUCLEIC ACIDS. Download PDFInfo
- Publication number
- NL8503597A NL8503597A NL8503597A NL8503597A NL8503597A NL 8503597 A NL8503597 A NL 8503597A NL 8503597 A NL8503597 A NL 8503597A NL 8503597 A NL8503597 A NL 8503597A NL 8503597 A NL8503597 A NL 8503597A
- Authority
- NL
- Netherlands
- Prior art keywords
- hybridization
- poly
- probe
- affinity pair
- affinity
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 30
- 150000007523 nucleic acids Chemical class 0.000 title claims description 25
- 108020004707 nucleic acids Proteins 0.000 title claims description 23
- 102000039446 nucleic acids Human genes 0.000 title claims description 23
- 239000000523 sample Substances 0.000 claims description 54
- 238000009396 hybridization Methods 0.000 claims description 33
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- 108010090804 Streptavidin Proteins 0.000 claims description 8
- 229960002685 biotin Drugs 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 108090001008 Avidin Proteins 0.000 claims description 3
- 229910001385 heavy metal Inorganic materials 0.000 claims description 2
- 125000004149 thio group Chemical group *S* 0.000 claims description 2
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000000243 solution Substances 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 20
- 239000013612 plasmid Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- 239000012634 fragment Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000001488 sodium phosphate Substances 0.000 description 5
- 229910000162 sodium phosphate Inorganic materials 0.000 description 5
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 241000701161 unidentified adenovirus Species 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229940038705 chlamydia trachomatis Drugs 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- BRLRJZRHRJEWJY-VCOUNFBDSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-[3-[3-(4-azido-2-nitroanilino)propyl-methylamino]propyl]pentanamide Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)NCCCN(C)CCCNC1=CC=C(N=[N+]=[N-])C=C1[N+]([O-])=O BRLRJZRHRJEWJY-VCOUNFBDSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241001131785 Escherichia coli HB101 Species 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 241000701109 Human adenovirus 2 Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- JGQHTPYIIXRFLR-UHFFFAOYSA-N [2-(9h-fluoren-1-yl)-2-oxoethyl] acetate Chemical class C1C2=CC=CC=C2C2=C1C(C(=O)COC(=O)C)=CC=C2 JGQHTPYIIXRFLR-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- -1 heme compounds Chemical class 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Description
» i..................................λ «»I .................................. λ«
Korte aanduiding: Werkwijze voor het identificeren van nucleïnezurenShort designation: Method for identifying nucleic acids
De uitvinding heeft betrekking op een werkwijze voor het identificeren van nucleïnezuren door middel van hybridisatie in oplossing. De werkwijze volgens de uitvinding wordt gekenmerkt doordat er ten minste twee sondes worden toegepast in de hybridisatiereactie. Aan de detectors’ sonde wordt een label bevestigd, en aan de andere sonde, de zogenaamde vangsonde ("capturing probe") wordt een component bevestigd met affiniteit voor een andere component waardoor de uit de hybridisatie resulterende vangsonde/doel-nucleïnezuur/detectorsonde-hybride kan worden afgescheiden van de andere in het hybridisatiemengsel aanwezige componenten.The invention relates to a method of identifying nucleic acids by hybridization in solution. The method of the invention is characterized in that at least two probes are used in the hybridization reaction. A label is attached to the detectors probe, and to the other probe, the so-called capture probe, a component with affinity for another component is attached, whereby the capture probe / target nucleic acid / detector probe hybrid resulting from the hybridization can be separated from the other components present in the hybridization mixture.
10 Verschillende hybridisatiemethoden zijn toegepast voor het identifi ceren van nucleïnezuren. Directe hybridisatiemethoden en sandwich-hybri-disatiemethoden kunnen als voorbeelden worden genoemd. In directe hybridisatiemethoden is het nucleïnezuurspecimen hetzij in oplossing, hetzij gebonden aan een vaste drager. Het te identificeren nucleïnezuur wordt 15 gedemonstreerd door toepassing van een gelabelde sonde. In sandwich-hybridisatiemethoden (Amerikaans octrooischrift 4 486 539) worden twee afzonderlijke sondes gebruikt door middel waarvan het te identificeren nucleïnezuur wordt gedemonstreerd in de monsteroplossing. De detector-sonde is gelabeld met een labelsubstantie en de andere sonde is gebonden 20 aan vaste drager.Various hybridization methods have been used to identify nucleic acids. Direct hybridization methods and sandwich hybridization methods can be mentioned as examples. In direct hybridization methods, the nucleic acid specimen is either in solution or bound to a solid support. The nucleic acid to be identified is demonstrated using a labeled probe. Sandwich hybridization methods (U.S. Patent 4,486,539) use two separate probes by which the nucleic acid to be identified is demonstrated in the sample solution. The detector probe is labeled with a label substance and the other probe is bound to solid support.
Een nieuwe hybridisatiemethode waarin twee verschillende sondes worden gebruikt en waarbij de beide sondes in de oplossingsfase zijn is ontwikkeld. Daar zowel het doel-nucleïnezuur dat deelneemt in de hybridisatie als de twee sondes in dezelfde oplossingsfase aanwezig zijn is de 25 hybridisatiereactie aanzienlijk sneller dan in sandwich-hybridisatie, waarbij de ene sonde aan een vaste drager is gehecht. In de werkwijze volgens de uitvinding is een incubatietijd van een uur voldoende. In de eentraps-sandwich-hybridisétie (Amerikaans octrooischrift 4 486 539) wordt voldoende .hybridisatie niet in minder dan 12 uur verwezenlijkt.A new hybridization method that uses two different probes and where both probes are in the solution phase has been developed. Since both the target nucleic acid participating in the hybridization and the two probes are in the same solution phase, the hybridization reaction is considerably faster than in sandwich hybridization, with one probe attached to a solid support. In the method according to the invention, an incubation time of one hour is sufficient. In the single-stage sandwich hybridization (U.S. Patent 4,486,539), sufficient hybridization is not accomplished in less than 12 hours.
30 Wanneer tweetraps-sandwich-hybridisatie (Dunn en Hassel, Cell, 12, 23-36 (1977)) wordt uitgevoerd is een hybridisatietijd van ten minste 24 uur vereist.When two-stage sandwich hybridization (Dunn and Hassel, Cell, 12, 23-36 (1977)) is performed, a hybridization time of at least 24 hours is required.
Ten minste twee sondes worden met voordeel toegepast in de werkwijze volgens de uitvinding. De sondes zijn nucleïnezuurfragmenten die voldoen-35 de homoloog zijn aan het doel-nucleïnezuur. Het is voordelig maar niet : :* i 7 - ·* ^ - » Γ - 2 - noodzakelijk dat de sondes homoloog zijn aan plaatsen die relatief dicht bij elkaar gelegen zijn in het te identificeren nuclelnezuur. De sondes moet niet-overlappend zijn met elkaar.At least two probes are advantageously used in the method according to the invention. The probes are nucleic acid fragments that are homologous to the target nucleic acid. It is advantageous but not: * i 7 - * ^ - »Γ - 2 - it is necessary that the probes are homologous to sites relatively close together in the nucleic acid to be identified. The probes must be non-overlapping with each other.
De sondes kunnen synthetisch, semi-synthetisch, met behulp van re-5 combinant-DNA-technieken of uit rechtstreeks uit de natuur geïsoleerde nucleïnezuren worden bereid. Sondes zijn ook commercieel verkrijgbaar uit diverse bronnen. Een sonde kan gebonden zijn aan een geschikte vector.The probes can be prepared synthetically, semi-synthetically, using recombinant DNA techniques or from nucleic acids isolated directly from nature. Probes are also commercially available from a variety of sources. A probe can be bound to a suitable vector.
De sonde kan vectordelen bevatten of volledig vrij zijn van vectordelen.The probe can contain vector parts or be completely free of vector parts.
De detectorsonde wordt gelabeld met een geschikt label. Diverse 10 radioactieve isotopen of radioactief gelabelde verbindingen kunnen als labels worden gebruikt. De labelsubstantie kan ook fluorescerend, luminescerend, licht-emitterend, enzymatisch of immunologisch demon-streerbaar, enz. zijn. Labels gebaseerd op biotine en avidine of strepta-vidine, lanthanide-chelaten, ferritine en heme-verbindingen, en immunolo-15 gisch demonstreerbare haptenen, zoals acetoxyacetylfluoreen-derivaten (WO 8302286) kunnen als voorbeelden worden genoemd. Identificatie door tussenkomst van eiwitten is ook mogelijk. De werkwijze volgens de uitvinding is niet afhankelijk van het gebruikte label. Alle op het ogenblik bekende labelsubstanties die geschikt zijn voor nucleïnezuur-hybridisa-20 tie, of die welke in de toekomst zullen worden ontwikkeld, kunnen vrijelijk op de werkwijze worden toegepast.The detector probe is labeled with an appropriate label. Various radioactive isotopes or radiolabeled compounds can be used as labels. The label substance can also be fluorescent, luminescent, light-emitting, enzymatic or immunologically demonstrable, etc. Labels based on biotin and avidin or streptavidin, lanthanide chelates, ferritin and heme compounds, and immunologically demonstrable hapten, such as acetoxyacetylfluorene derivatives (WO 8302286) can be mentioned as examples. Identification through proteins is also possible. The method according to the invention does not depend on the label used. All currently known label substances suitable for nucleic acid hybridization, or those which will be developed in the future, can be freely applied to the method.
Aan de andere sonde, de zogenaamde vangsonde, is een component met affiniteit voor een andere component bevestigd. Biotine / avidine of streptavidine, zwaar-metaal-derivaten / thio-groepen, diverse homopoly-25 nucleotiden, zoals poly-dG / poly-dC, poly-dA / poly-dT en poly-dA / poly-U zijn geschikte affiniteitsparen. Maar ook andere affiniteitsparen kunnen worden toegepast, mits de componenten voldoende sterke affiniteit voor elkaar hebben. Geschikte affiniteitsparen worden gevonden onder liganden en conjugaten die in immunologische methoden worden toegepast.A component with affinity for another component is attached to the other probe, the so-called capture probe. Biotin / avidin or streptavidin, heavy metal derivatives / thio groups, various homopoly nucleotides such as poly-dG / poly-dC, poly-dA / poly-dT and poly-dA / poly-U are suitable affinity pairs. But other affinity pairs can also be used, provided that the components have sufficiently strong affinity for each other. Suitable affinity pairs are found among ligands and conjugates used in immunological methods.
30 Voordat de hybridisatiereactie wordt uitgevoerd wordt het specimen behandeld om de doel-nucleïnezuren in enkel-strengs-vorm vrij te maken in de hybridisatie-oplossing. De hybridisatie wordt uitgevoerd in een hybri-disatie-mengsel waarin de doel-nucleïnezuren, de gelabelde sonde en de vangsonde zonodig enkel-strengs zijn gemaakt. Diverse geschikte buffers 35 kunnen worden gebruikt als hybridisatie-oplossingen. pe hybridisatie vindt plaats binnen het temperatuurtraject van 0-80°C, maar het is voordelig een temperatuur van 65°C toe te passen. Indien de hybridisatie-oplossing formamide bevat (40-55%) kan een temperatuur van 37°C worden toegepast. Een uur is voldoende als hybridisatietijd.Before the hybridization reaction is performed, the specimen is treated to release the target nucleic acids in single strand form in the hybridization solution. Hybridization is carried out in a hybridization mixture in which the target nucleic acids, the labeled probe and the capture probe are made single stranded, if necessary. Various suitable buffers can be used as hybridization solutions. Hybridization takes place within the temperature range of 0-80 ° C, but it is advantageous to use a temperature of 65 ° C. If the hybridization solution contains formamide (40-55%), a temperature of 37 ° C can be used. One hour is sufficient as a hybridization time.
Λ «Λ **·. . Λ » ·. 4 / -- ·· · v -J jΛ «Λ ** ·. . Λ »·. 4 / - ·· · v -J j
4r .............................A4r ............................. A
- 3 -- 3 -
Wanneer de hybridisatie heeft plaatsgevonden wordt de oplossing zonodig verdund om de omstandigheden voordelig te maken voor het affini-teitspaar. Daarna wordt het mengsel in contact gebracht met het andere lid van het affiniteitspaar. Affiniteitschromatografiekolommen, filters, 5 kunststofoppervlakken, glasoppervlakken, enz., kunnen worden toegepast om de vangsonde/doel-nucleïnezuur/detectorsonde-hybride te vangen.When hybridization has occurred, the solution is diluted as necessary to make the conditions beneficial to the affinity pair. The mixture is then contacted with the other member of the affinity pair. Affinity chromatography columns, filters, plastic surfaces, glass surfaces, etc. can be used to capture the capture probe / target nucleic acid / detector probe hybrid.
Het dragermateriaal van de affiniteitskolom kan bijvoorbeeld cellulose, latex, polyacrylamide, dextran of agarose zijn. Deze materialen kunnen ook als suspensies worden gebruikt in een reageerbuis. Het is ook 10 voordelig reageerbuizen toe te passen waarbij de andere component van het affiniteitspaar aan de binnenoppervlak daarvan is gebonden. Het is een vereiste voor het gekozen materiaal dat het raogelijk is daaraan een component te binden die affiniteit heeft voor de aan de vangsonde bevestigde component.The support material of the affinity column can be, for example, cellulose, latex, polyacrylamide, dextran or agarose. These materials can also be used as suspensions in a test tube. It is also advantageous to use test tubes in which the other component of the affinity pair is bound to its inner surface. It is a requirement for the selected material that it is possible to bind to it a component that has affinity for the component attached to the capture probe.
15 Indien het specimen het te identificeren nucleïnezuur bevat resul teert er een vangsonde/doel-nucleïnezuur/detectorsonde-hybride uit de hybridisatie. Tijdens fractionering hecht deze hybride zich aan de drager. Het label van de zich aan de drager hechtende fractie kan met conventionele methoden worden gemeten, rechtstreeks vanaf de drager of na 20 elutie vanuit de geëlueerde oplossing.If the specimen contains the nucleic acid to be identified, a capture probe / target nucleic acid / detector probe hybrid results from the hybridization. During fractionation, this hybrid attaches to the support. The label of the fraction adhering to the support can be measured by conventional methods, directly from the support or after elution from the eluted solution.
Andere systemen, bijvoorbeeld fase-extractie of magnetische velden, kunnen ook bij de fractionering worden toegepast in plaats van affiniteitschromatografie.Other systems, for example phase extraction or magnetic fields, can also be used in fractionation instead of affinity chromatography.
De werkwijze volgens de uitvinding wordt in meer detail beschreven 25 in de volgende voorbeelden. De werkwijze volgens de uitvinding is niet afhankelijk van de in de voorbeelden toegepaste nuclelnezuurfragmenten.The method of the invention is described in more detail in the following examples. The method according to the invention does not depend on the nucleic acid fragments used in the examples.
Voorbeeld 1Example 1
Identificatie van het DNA van adenovirus uit een cel-lysaat door het zuur van homopolynucleotiden 30 De toegepaste detectorsonde is met 12% gelabelde recombinant-faag mKTH 1206 die een Bgl II-fragment van het adenovirus-genoom uit positie 42-45,3% op de genenkaart van het adenovirus type 2 bevat. De recombi-nant-faag is onder nummer DSM 2827 gedeponeerd in de cultuurcollectie Deutsche Sammlung von Mikroorganismen. De specifieke activiteit ervan is 35 7x10^ cpm/ug DNA. De sonde wordt in meer detail beschreven in Ranki e.a., Gene 21, 77-85 Π983).Identification of adenovirus DNA from a cell lysate by the acid of homopolynucleotides. The detector probe used is 12% labeled recombinant phage mKTH 1206 containing a Bgl II fragment of the adenovirus genome from position 42-45.3% at contains the gene map of the adenovirus type 2. The recombinant phage has been deposited under number DSM 2827 in the culture collection Deutsche Sammlung von Mikroorganismen. Its specific activity is 7x10x10 cpm / µg DNA. The probe is described in more detail in Ranki et al., Gene 21, 77-85 Π983).
De toegepaste vangsonde is de recombinant-plasmide pKTH 1202, die onder nummer DSM 2824 is gedeponeerd in de cultuurcollectie Deutsche Sammlung von Mikroorganismen. Deze omvat een BamHI D-fragment van het \ · - 4 - adenovirus (kaartpositie 29-42%) gekloond in de plasmide pBR322. De recorabinant-plasmide pKTH 1202 (DSM 2824) werd gefragmenteerd onder toepassing van het restrictie-enzym Hae III en een poly-A-staart werd verbonden met de 3'-uiteinden van de fragmenten onder toepassing van 5 terminaarl transferase-enzym . De lengte van de staart werd gemeten door 2H-A-opneming. De lengte was gemiddeld ongeveer 70 A-resten. Alvorens te worden gebruikt werd de vangsonde gedenatureerd door koken.The capture probe used is the recombinant plasmid pKTH 1202, which has been deposited under number DSM 2824 in the culture collection Deutsche Sammlung von Mikroorganismen. This includes a BamHI D fragment of the a4 adenovirus (map position 29-42%) cloned into the plasmid pBR322. The recorabinant plasmid pKTH 1202 (DSM 2824) was fragmented using the restriction enzyme Hae III and a poly-A tail was linked to the 3 'ends of the fragments using 5 term transferase enzyme. Tail length was measured by 2H-A incorporation. The length averaged about 70 A residues. The capture probe was denatured by boiling before use.
Het gebruikte monster bestond uit met adenovirus geïnfecteerde A-549-cellen. De cellen werden 21 uur geïncubeerd na de infectie. De 10 cellen werden verzameld en gelyseerd onder toepassing van een 1%’ige £ natriumdodecylsulfaat-oplossing. De oplossing bevatte ongeveer 10° cel-len/ml. De viscositeit ervan werd verlaagd door sonicatie. Op identieke wijze behandelde niet-geïnfecteerde A-549-cellen werden als controle gebruikt. Voor hybridisatie werd het specimen 5 min gekookt in 0,02 M 15 NaOH, tot 0°C gekoeld, en met azijnzuur geneutraliseerd.The sample used consisted of adenovirus infected A-549 cells. The cells were incubated 21 hours after the infection. The 10 cells were collected and lysed using a 1% sodium dodecyl sulfate solution. The solution contained about 10 ° cells / ml. Its viscosity was reduced by sonication. Identically treated uninfected A-549 cells were used as a control. Before hybridization, the specimen was boiled in 0.02 M 15 NaOH, cooled to 0 ° C, and neutralized with acetic acid.
Voor de test werden 500.000 cpm detectorsonde, 50 ng vangsonde-DNA en 10 yl specimen in een reageerbuis gecombineerd. Het volume werd op 50 yl gebracht en de gebruikte bufferoplossing was 0,6 M natriumchloride, 0,06 M natriumcitraat, 0,02 M natriumfosfaat (pH 7,6) en 0,5% natrium-20 dodecylsulfaat. Het mengsel werd 1 uur bij 65°C geïncubeerd.For the test, 500,000 cpm detector probe, 50 ng capture probe DNA and 10 µl specimen were combined in a test tube. The volume was adjusted to 50 µl and the buffer solution used was 0.6 M sodium chloride, 0.06 M sodium citrate, 0.02 M sodium phosphate (pH 7.6) and 0.5% sodium 20 dodecyl sulfate. The mixture was incubated at 65 ° C for 1 hour.
Na de hybridisatie werd de oplossing gekoeld tot +20°C en langzaam door een chromatografiekolom met 1 ml oligo-dT-cellulose gevoerd. De oplossing die doorkwam werd gewonnen en opnieuw door de kolom gevoerd. Daarna werd de kolom gewassen met 20 ml van een oplossing die 0,15 M 25 natriumchloride, 0,015 M natriumfosfaat (pH 7,6) en 0,5% natriumdodecyl-sulfaat bevatte. Het vastgelegde DNA werd tenslotte losgemaakt onder toepassing van 1 ml 0,02 M NaOH. Deze oplossing werd gewonnen en de radioactiviteit ervan werd bepaald.After hybridization, the solution was cooled to + 20 ° C and slowly passed through a chromatography column with 1 ml oligo-dT cellulose. The solution that came through was collected and passed through the column again. The column was then washed with 20 ml of a solution containing 0.15 M sodium chloride, 0.015 M sodium phosphate (pH 7.6) and 0.5% sodium dodecyl sulfate. The captured DNA was finally released using 1 ml 0.02 M NaOH. This solution was collected and its radioactivity determined.
Resultaat; 12^I-activiteit (cpm) 30 Doel-nucleïnezuur: Geïnfecteerde cellen Controle-cellen 5230 325Result; 12 ^ I activity (cpm). Target nucleic acid: Infected cells. Control cells 5230 325
Voorbeeld 2Example 2
Identificatie van het DNA van Chlamydia trachomatis met behulp van biotine/streptavidine , 35 De gebruikte detectorsonde was met 12^I gelabelde recombinant-faag mKTH 1245 die twee BamHI-Sall-DNA-fragmenten uit de kloon pKTH 1220 bevat, die tezamen aan de M13mp8-vector verknoopt zijn. De kloon pKTH 1220 is onder nummer DSM 2825 gedeponeerd in de cultuurcollectie Deutsche ?'* . ' ' j 7 * <· - 5 -Identification of the DNA of Chlamydia trachomatis using biotin / streptavidin. The detector probe used was 12 µl-labeled recombinant phage mKTH 1245 containing two BamHI-Sall DNA fragments from the clone pKTH 1220, which together are attached to the M13mp8 vector are cross-linked. The clone pKTH 1220 has been deposited under number DSM 2825 in the culture collection Deutsche? '*. '' j 7 * <- - 5 -
Sammlung von Mikroorganismen en is beschreven in Palva e.a., FEMS Microbiology Letters 23, 33-39 (1934).Sammlung von Microorganisms and is described in Palva et al., FEMS Microbiology Letters 23, 33-39 (1934).
De toegepaste vangsonde was de recombinant-plasmide pKTH 1250.The capture probe used was the recombinant plasmid pKTH 1250.
Deze plasmide bestaat uit een 2,9 kb Sall-Clal-fragment uit de plasmide 5 pKTH 1220 (DSM 2825) en uit de vector pAT 153. Biotine-moleculen werden covalent verknoopt met het pKTH 1250 DNA onder toepassing van de bekende ,,nick-translation,, methode (Rigby e.a., J. Mol. Biol. 113, 237-251 (1977)) en het biotine-11-UTP als substraat (Bethesda Research Laboratories). Het vangsonde-DNA werd voor gebruik 5 min gekookt in een buffer 10 die 10 mM Tris-Cl pH 7,6, 1 mM EDTA omvatte.This plasmid consists of a 2.9 kb Sall-Clal fragment from the plasmid pKTH 1220 (DSM 2825) and from the vector pAT 153. Biotin molecules were covalently cross-linked with the pKTH 1250 DNA using the known nick translation method (Rigby et al., J. Mol. Biol. 113, 237-251 (1977)) and the biotin-11-UTP as substrate (Bethesda Research Laboratories). The capture probe DNA was boiled for 5 min in a buffer containing 10 mM Tris-Cl pH 7.6, 1 mM EDTA before use.
Het doel-nucleïnezuur was de recombinant-plasmide pKTH 1220 (DSM 2825). Deze plasmide bevat ongeveer 10 kb van het DNA dat karakteristiek is voor Chlamydia trachomatis, verknoopt met de vector pBR322. De plasmide fungeert als model-DNA, het genoom-DNA van het bacterium vertegenwoor-15 digend. Voorafgaand aan gebruik werd de plasmide 5 min gekookt in 0,02 M NaOH, waarna de oplossing met azijnzuur werd geneutraliseerd.The target nucleic acid was the recombinant plasmid pKTH 1220 (DSM 2825). This plasmid contains about 10 kb of the DNA characteristic of Chlamydia trachomatis cross-linked with the vector pBR322. The plasmid functions as model DNA, representing the genomic DNA of the bacterium. Before use, the plasmid was boiled in 0.02 M NaOH for 5 min, after which the solution was neutralized with acetic acid.
Streptavidine, dat als affiniteitsmateriaal werd gebruikt, werd bevestigd aan met CNBr geactiveerde Sepharose (Pharmacia) volgens Axen e.a., Nature 214, 1302-1304 (1967).Streptavidin, which was used as an affinity material, was attached to CNBr-activated Sepharose (Pharmacia) according to Axen et al., Nature 214, 1302-1304 (1967).
20 Voor de test werden 500.000 cpm sonde, 50 ng vangsonde-DNA en 10 ng doel-DNA in een reageerbuis gecombineerd. Het volume werd op 20 pl gebracht en de bufferoplossing was dezelfde als in Voorbeeld 1. Het contro-le-DNA was kalverthymus-DNA.For the test, 500,000 cpm probe, 50 ng capture probe DNA and 10 ng target DNA were combined in a test tube. The volume was adjusted to 20 µl and the buffer solution was the same as in Example 1. The control DNA was calf thymus DNA.
Het mengsel werd 60 min bij 65°C geïncubeerd. Daarna werd 500 μΐ 25 van een bufferoplossing met de samenstelling 0,1 M Tris-Cl pH 7,5, 0,1 M NaCl, 2 mM MgCl2, 0,05% Triton X-100 toegevoegd. Tenslotte werd de oplossing gefractioneerd in een 0,2 ml Streptavidine-Sepharose-kolom. De kolom werd gewassen met 10 ml van de bovengenoemde buffer en 10 ml 0,015 M natriumchloride, 0,015 M natriumfosfaat (pH 7,6), 0,5 % natriumdodecyl-30 sulfaat (50°C). Aldus hechtte het gebiotinyleerde DNA aan het Streptavidine, terwijl het andere DMA door de kolom passeerde. De radioactieve sonde hechtte slechts als resultaat van hybridevorming. De gevangen radioactiviteit werd bepaald door overbrenging van de gehele kolom in de telbuis van een gamma-teller.The mixture was incubated at 65 ° C for 60 min. Then 500 µl of a buffer solution of the composition 0.1 M Tris-Cl pH 7.5, 0.1 M NaCl, 2 mM MgCl 2, 0.05% Triton X-100 was added. Finally, the solution was fractionated in a 0.2 ml Streptavidin Sepharose column. The column was washed with 10 ml of the above buffer and 10 ml of 0.015 M sodium chloride, 0.015 M sodium phosphate (pH 7.6), 0.5% sodium dodecyl-30 sulfate (50 ° C). Thus, the biotinylated DNA attached to the Streptavidin while the other DMA passed through the column. The radioactive probe adhered only as a result of hybrid formation. The captured radioactivity was determined by transferring the entire column into the counter of a gamma counter.
35 Resultaat: 12^I-activiteit (cpm)35 Result: 12 ^ I activity (cpm)
Doel-nucleïnezuur: 10 ng pkTH 1220 10 ng Controle-DNATarget nucleic acid: 10 ng pkTH 1220 10 ng Control DNA
1350 115 - " 71350 115 - "7
I VIV
¥ > - 6 -¥> - 6 -
Voorbeeld 3Example 3
Identificatie van piasmide pBR322 DNA met behulp van een antigen-antilichaam-paarIdentification of piasmid pBR322 DNA using an antigen-antibody pair
De gebruikte detectorsonde is een derivaat van de plasmide pBR322 5 (commercieel verkrijgbaar uit diverse bronnen) waaruit het Pstl-Sall (3613-651) fragment is verwijderd. De plasmide werd gelabeld met fotobio-tine onder toepassing van een bekende methode (Forster e.a., Nucleic Acids Res. 13, 745-761 (1985)) en van commerciële reagentia (Bresa, Adelaide, Aus tralie).The detector probe used is a derivative of the plasmid pBR322 (commercially available from various sources) from which the Pstl-Sall (3613-651) fragment has been removed. The plasmid was labeled with photobiotin using a known method (Forster et al., Nucleic Acids Res. 13, 745-761 (1985)) and commercial reagents (Bresa, Adelaide, Aus gralie).
10 De toegepaste vangsonde was DNA uit een recombinant-faag M13mp11 waarin het pBR322 Pstl-Sall-fragment was geïntroduceerd. Het DNA was gesulfoneerd onder toepassing van een bekende methode (Orgenics Ltd, Yavne, Israël).The capture probe used was DNA from a recombinant phage M13mp11 into which the pBR322 Pst1-Sall fragment had been introduced. The DNA was sulfonated by a known method (Orgenics Ltd, Yavne, Israel).
Het specimen was E. coli HB101 dat de plasmide pBR322 droeg, de 15 hoeveelheid waarvan werd verhoogd onder toepassing van chlooramfenicol-versterking (Maniatis e.a., Molecular cloning, A laboratory manual, Cold Spring Harbor Laboratory 1982). De bacteriële cellen werden gelyseerd met lysozyme, gevolgd door koken in NaOH als beschreven in de publicatie Palva, J. Clin. Microbiol. 18, 92-100 (1983).The specimen was E. coli HB101 carrying the plasmid pBR322, the amount of which was increased using chloramphenicol amplification (Maniatis et al., Molecular cloning, A laboratory manual, Cold Spring Harbor Laboratory 1982). The bacterial cells were lysed with lysozyme followed by boiling in NaOH as described in the publication Palva, J. Clin. Microbiol. 18, 92-100 (1983).
20 Antisulfon monoklonale antilichamen werden gebruikt om polystyreen- microtiter-platen te bekleden door standaardmethoden (McKearn, in Hybri-domas: A New Dimension in Biological Analyses, ed. Kennett e.a., Plenum Press 1980).Antisulfone monoclonal antibodies were used to coat polystyrene microtiter plates by standard methods (McKearn, in Hybri-domas: A New Dimension in Biological Analyzes, ed. Kennett et al., Plenum Press 1980).
Voor de test werden 5x10^ gelyseerde Ξ. coli-cellen (zowel met als 25 zonder pBR322) gecombineerd met 100 ng vang-DNA en 100 hg detectorsonde in een 50 yl hybridisatieraengsel. De omstandigheden waren als in Voorbeeld 1, uitgezonderd dat 5% polyethyleenglycol (PEG 6000) aan het mengsel werd toegevoegd en dat de natriumdodecylsulfaatconcentratie 0,1% was. Na hybridisatie werd de oplossing tot 250 yl verdund door toevoeging van 30 0,02 M natriumfosfaat (pH 7,6), waarna de oplossing werd overgebracht naar de met antilichaam beklede microtiter-plaat. Dit werd gevolgd door twee uur incuberen bij 37°C. De plaat werd vervolgens gewassen met een oplossing die 0,015 M natriumchloride, 0,02 M natriumfosfaat pH 7,6 en 0,05% Triton X-100 bevatte. De aanwezigheid van detectorsonde werd zicht-„ 35 baar gemaakt door toevoeging van streptavidine (Bethesda Research Laboratories BRL), wassen, toevoegen van gebiotinyleerde alkalische fosfatase (BRL), en wassen als beschreven door Leary e.a., Proc. Natl. Acad. Sci. USA 80, 4045-4049 (1983). Tenslotte werd 250 μ 1 van een oplossing van 35 mg/1 paranitrofenylfosfaat (Sigma) in diëthanolaminebuffer (pH 10) : ' .· - V7 ^ v * * .....For the test, 5x10 ^ were lysed Ξ. coli cells (both with and without pBR322) combined with 100 ng capture DNA and 100 hg detector probe in a 50 µl hybridization mixture. The conditions were as in Example 1 except that 5% polyethylene glycol (PEG 6000) was added to the mixture and the sodium dodecyl sulfate concentration was 0.1%. After hybridization, the solution was diluted to 250 µl by adding 0.02 M sodium phosphate (pH 7.6) and the solution was transferred to the antibody-coated microtiter plate. This was followed by incubation at 37 ° C for two hours. The plate was then washed with a solution containing 0.015 M sodium chloride, 0.02 M sodium phosphate pH 7.6 and 0.05% Triton X-100. The presence of detector probe was visualized by adding streptavidin (Bethesda Research Laboratories BRL), washing, adding biotinylated alkaline phosphatase (BRL), and washing as described by Leary et al., Proc. Natl. Acad. Sci. USA 80, 4045-4049 (1983). Finally, 250 μl of a solution of 35 mg / l paranitrophenylphosphate (Sigma) in diethanolamine buffer (pH 10) was added: -. - V7 ^ v * * .....
t - 7 - toegevoegd. Na 60 min werd de reactie beëindigd en werd het absorberend vermogen gemeten bij 410 nm.t - 7 - added. After 60 min, the reaction was stopped and the absorbance was measured at 410 nm.
Ssgultaat: A41Q nmSsult: A41Q nm
Doei-nucleïnezuur: Geilen met pBR322 Cellen zonder pBR322 5 >2 0,15 o 2 ' l j 7Di-nucleic acid: Horns with pBR322 Cells without pBR322 5> 2 0.15 o 2 'l j 7
Claims (8)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI850004 | 1985-01-02 | ||
| FI850004A FI72146C (en) | 1985-01-02 | 1985-01-02 | Procedure for Identifying Nucleic Acids. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8503597A true NL8503597A (en) | 1986-08-01 |
| NL189427B NL189427B (en) | 1992-11-02 |
| NL189427C NL189427C (en) | 1993-04-01 |
Family
ID=8520136
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE8503597,A NL189427C (en) | 1985-01-02 | 1985-12-31 | METHOD FOR IDENTIFYING NUCLEIC ACIDS. |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPH0669400B2 (en) |
| AT (1) | AT397514B (en) |
| AU (1) | AU561382B2 (en) |
| BE (1) | BE903937A (en) |
| CA (1) | CA1271705A (en) |
| CH (1) | CH666696A5 (en) |
| DE (1) | DE3546312A1 (en) |
| DK (1) | DK164932C (en) |
| FI (1) | FI72146C (en) |
| FR (1) | FR2575493B1 (en) |
| GB (1) | GB2169403B (en) |
| HU (1) | HU196453B (en) |
| IE (1) | IE58290B1 (en) |
| IL (1) | IL77489A (en) |
| IT (1) | IT1201514B (en) |
| LU (1) | LU86238A1 (en) |
| NL (1) | NL189427C (en) |
| NO (1) | NO166743C (en) |
| RO (1) | RO94651B (en) |
| SE (1) | SE463212B (en) |
| ZA (1) | ZA859895B (en) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5288609A (en) * | 1984-04-27 | 1994-02-22 | Enzo Diagnostics, Inc. | Capture sandwich hybridization method and composition |
| US6060237A (en) * | 1985-02-26 | 2000-05-09 | Biostar, Inc. | Devices and methods for optical detection of nucleic acid hybridization |
| ES8707343A1 (en) * | 1985-06-13 | 1987-07-16 | Amgen | Method for performing nucleic acid hybridization assays. |
| US4910300A (en) * | 1985-12-11 | 1990-03-20 | Chiron Corporation | Method for making nucleic acid probes |
| US4868105A (en) * | 1985-12-11 | 1989-09-19 | Chiron Corporation | Solution phase nucleic acid sandwich assay |
| US4882269A (en) * | 1985-12-13 | 1989-11-21 | Princeton University | Amplified hybridization assay |
| FI76119C (en) * | 1986-02-27 | 1988-09-09 | Orion Yhtymae Oy | QUANTITATIVE BEARING OF NUCLEIN SYRAMOLEKYLER AND REAGENTS FOERPACKNING SOM ANVAENDS VID FOERFARANDET. |
| AU622104B2 (en) * | 1987-03-11 | 1992-04-02 | Sangtec Molecular Diagnostics Ab | Method of assaying of nucleic acids, a reagent combination and kit therefore |
| EP0296557A3 (en) * | 1987-06-26 | 1990-06-20 | E.I. Du Pont De Nemours And Company | Affinity removal of contaminating sequences from recombinant cloned na using capture beads |
| AU623090B2 (en) * | 1987-07-31 | 1992-05-07 | Gen-Probe Incorporated | Assay for polynucleotides employing oligonucleotides to eliminate undesirable cross reactions |
| EP0305145A3 (en) * | 1987-08-24 | 1990-05-02 | Ortho Diagnostic Systems Inc. | Methods and probes for detecting nucleic acids |
| EP0304845A3 (en) * | 1987-08-28 | 1991-03-06 | Profile Diagnostic Sciences Inc. | Method and kit for assaying gene expressions |
| CA1325761C (en) * | 1987-12-25 | 1994-01-04 | Takanori Oka | Method of detecting an intended nucleic acid in a sample |
| DE3800644A1 (en) * | 1988-01-12 | 1989-07-20 | Boehringer Mannheim Gmbh | PROCESS FOR HIGHLY SPECIFIC DETECTION OF NUCLEIC ACIDS IN SOLUTION |
| US5104791A (en) * | 1988-02-09 | 1992-04-14 | E. I. Du Pont De Nemours And Company | Particle counting nucleic acid hybridization assays |
| EP0436547B1 (en) * | 1988-05-10 | 1994-11-30 | E.I. Du Pont De Nemours And Company | Process for rapid nucleic acid detection |
| US5185243A (en) * | 1988-08-25 | 1993-02-09 | Syntex (U.S.A.) Inc. | Method for detection of specific nucleic acid sequences |
| AU629845B2 (en) * | 1988-08-30 | 1992-10-15 | Abbott Laboratories | Detection and amplification of target nucleic acid sequences |
| US5858652A (en) * | 1988-08-30 | 1999-01-12 | Abbott Laboratories | Detection and amplification of target nucleic acid sequences |
| GB2225112A (en) * | 1988-11-22 | 1990-05-23 | Ici Plc | Hybridisation probes |
| US5082935A (en) * | 1988-12-15 | 1992-01-21 | Amoco Corporation | Diagnostic reagents made by attaching cytidine containing nucleic acid probes to amino functionalized solid supports by bisulfite mediated transamination |
| AU5188190A (en) * | 1989-02-06 | 1990-08-24 | Gene-Trak Systems | Probes and methods for the detection of listeria |
| WO1990010717A1 (en) * | 1989-03-10 | 1990-09-20 | Gene-Trak Systems | Preventing interference with affinity capture schemes |
| DE69017204T2 (en) | 1989-03-10 | 1995-08-03 | Amoco Corp | IMMOBILIZED OLIGONUCLEOTIDE PROBE AND THEIR USE. |
| JPH05501052A (en) * | 1989-07-11 | 1993-03-04 | マイクロプローブ・コーポレーション | Quantification of bacteria using a nucleic acid hybridization assay |
| US5334501A (en) * | 1989-07-11 | 1994-08-02 | Microprobe Corporation | Quantification of bacteria using a nucleic acid hybridization assay |
| GB8924989D0 (en) * | 1989-11-06 | 1989-12-28 | Scotgen Ltd | Method and device for the detection of antibiotic resistance |
| US5580970A (en) * | 1989-12-01 | 1996-12-03 | Amoco Corporation | Detection of HPV transcripts |
| AU7429591A (en) * | 1990-04-18 | 1991-10-24 | Gene-Trak Systems | Nucleic acid probes for the detection of giardia lamblia |
| EP0529070A1 (en) * | 1991-02-27 | 1993-03-03 | Amoco Corporation | Methods for improving the sensitivity of hybridization assays |
| WO1993020234A1 (en) * | 1992-03-31 | 1993-10-14 | E.I. Du Pont De Nemours And Company | A rapid, high capacity nucleic acid based assay |
| US7713528B1 (en) | 1993-02-18 | 2010-05-11 | Enzo Therapeutics, Inc. | Method for in vivo delivery of active compounds using reagent conjugate |
| RU2146707C1 (en) * | 1996-04-11 | 2000-03-20 | Куликова Валентина Филипповна | Method of detection of analyzed sequence of nucleic acid |
| US5853993A (en) * | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
| GB0016833D0 (en) | 2000-07-07 | 2000-08-30 | Lee Helen | Improved dipstick assays (2) |
| US7465540B2 (en) | 2000-09-21 | 2008-12-16 | Luminex Corporation | Multiple reporter read-out for bioassays |
| CN1303221C (en) * | 2003-01-27 | 2007-03-07 | 英科新创(厦门)科技有限公司 | Method for detecting target nucleic acid using affinity amplifying integrated signal group |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0124221A1 (en) * | 1983-03-09 | 1984-11-07 | Alan David Blair Malcolm | Method of detecting a polynucleotide sequence and labelled polynucleotides useful therein |
| EP0128332A1 (en) * | 1983-05-05 | 1984-12-19 | Enzo Biochem, Inc. | Assay method utilizing polynucleotide sequences |
| EP0139489A2 (en) * | 1983-09-26 | 1985-05-02 | Ortho Diagnostic Systems Inc. | Sandwich hybridization method for nucleic acid detection |
| EP0152886A2 (en) * | 1984-02-22 | 1985-08-28 | Molecular Diagnostics, Inc. | Immobilized nucleic acid-containing probes |
| EP0158757A1 (en) * | 1984-02-28 | 1985-10-23 | Mors | Method and apparatus for controlling with precision the pressure drop in a fluidum |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI63596C (en) * | 1981-10-16 | 1983-07-11 | Orion Yhtymae Oy | MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER |
| FR2518755B1 (en) * | 1981-12-23 | 1986-04-11 | Pasteur Institut | PROBE CONTAINING MODIFIED NUCLEIC ACID RECOGNIZABLE BY SPECIFIC ANTIBODIES AND USE OF THE SAME TO DETECT AND CHARACTERIZE A HOMOLOGATED DNA SEQUENCE |
| ZA849596B (en) * | 1983-12-12 | 1985-07-31 | Miles Lab | Hybridization assay with immobilization of hybrids by anti-hybrid binding |
| FR2558172B1 (en) * | 1984-01-16 | 1986-06-13 | Inst Nat Sante Rech Med | PROBE CONTAINING MODIFIED NUCLEIC ACID AND RECOGNITION BY SPECIFIC ANTIBODIES AND USE OF SUCH PROBE AND THESE SPECIFIC ANTIBODIES TO DETECT AND CHARACTERIZE A HOMOLOGATED DNA SEQUENCE |
| NZ211453A (en) * | 1984-03-22 | 1989-01-06 | Biotechnology Research Enterpr | Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides |
| US4766062A (en) * | 1984-05-07 | 1988-08-23 | Allied Corporation | Displacement polynucleotide assay method and polynucleotide complex reagent therefor |
-
1985
- 1985-01-02 FI FI850004A patent/FI72146C/en not_active IP Right Cessation
- 1985-12-17 CH CH5378/85A patent/CH666696A5/en not_active IP Right Cessation
- 1985-12-20 GB GB08531414A patent/GB2169403B/en not_active Expired
- 1985-12-24 BE BE0/216059A patent/BE903937A/en not_active IP Right Cessation
- 1985-12-27 NO NO855308A patent/NO166743C/en not_active IP Right Cessation
- 1985-12-27 JP JP60299797A patent/JPH0669400B2/en not_active Expired - Lifetime
- 1985-12-29 HU HU855030A patent/HU196453B/en unknown
- 1985-12-30 FR FR858519394A patent/FR2575493B1/en not_active Expired - Lifetime
- 1985-12-30 ZA ZA859895A patent/ZA859895B/en unknown
- 1985-12-30 DE DE19853546312 patent/DE3546312A1/en active Granted
- 1985-12-30 IT IT23408/85A patent/IT1201514B/en active
- 1985-12-30 RO RO121637A patent/RO94651B/en unknown
- 1985-12-30 AT AT0376785A patent/AT397514B/en not_active IP Right Cessation
- 1985-12-30 LU LU86238A patent/LU86238A1/en unknown
- 1985-12-31 IL IL77489A patent/IL77489A/en not_active IP Right Cessation
- 1985-12-31 AU AU51748/85A patent/AU561382B2/en not_active Expired
- 1985-12-31 IE IE333385A patent/IE58290B1/en not_active IP Right Cessation
- 1985-12-31 NL NLAANVRAGE8503597,A patent/NL189427C/en not_active IP Right Cessation
- 1985-12-31 CA CA000498834A patent/CA1271705A/en not_active Expired - Lifetime
-
1986
- 1986-01-02 SE SE8600011A patent/SE463212B/en not_active IP Right Cessation
- 1986-01-02 DK DK000386A patent/DK164932C/en not_active IP Right Cessation
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0124221A1 (en) * | 1983-03-09 | 1984-11-07 | Alan David Blair Malcolm | Method of detecting a polynucleotide sequence and labelled polynucleotides useful therein |
| EP0128332A1 (en) * | 1983-05-05 | 1984-12-19 | Enzo Biochem, Inc. | Assay method utilizing polynucleotide sequences |
| EP0139489A2 (en) * | 1983-09-26 | 1985-05-02 | Ortho Diagnostic Systems Inc. | Sandwich hybridization method for nucleic acid detection |
| EP0152886A2 (en) * | 1984-02-22 | 1985-08-28 | Molecular Diagnostics, Inc. | Immobilized nucleic acid-containing probes |
| EP0158757A1 (en) * | 1984-02-28 | 1985-10-23 | Mors | Method and apparatus for controlling with precision the pressure drop in a fluidum |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL8503597A (en) | METHOD FOR IDENTIFYING NUCLEIC ACIDS. | |
| EP0464067B1 (en) | Solid phase diagnosis of medical conditions | |
| US5629158A (en) | Solid phase diagnosis of medical conditions | |
| US4563417A (en) | Nucleic acid hybridization assay employing antibodies to intercalation complexes | |
| EP0920532B1 (en) | Detection of differences in nucleic acids | |
| JPS62103570A (en) | Method of measuring homogeneous system of specific polynucleotides | |
| NL8800594A (en) | METHOD FOR DETERMINING NUCLEIC ACIDS AND REAGENT COMBINATION AND KIT FOR THAT. | |
| US5981171A (en) | Diagnostic assays using nucleic acid probes | |
| WO1990002205A1 (en) | Detection of nucleic acid sequences using particle agglutination | |
| Dahlén et al. | Sensitive detection of genes by sandwich hybridization and time-resolved fluorometry | |
| JPH0630637B2 (en) | Nucleic acid detection method by separation | |
| EP0146815B1 (en) | Nucleic acid hybridization assay employing antibodies to intercalation complexes | |
| US4840892A (en) | Polynucleotide hybridization probes | |
| Stark et al. | Immunomagnetic separation and solid-phase detection of Bordetella pertussis | |
| EP0172153B1 (en) | Polynucleotide hybridization probes | |
| Hupp et al. | Activation of DnaA5 protein by GrpE and DnaK heat shock proteins in initiation of DNA replication in Escherichia coli | |
| WO2000043543A1 (en) | Detection of differences between polynucleotides | |
| WO2000043545A2 (en) | Detection of drug resistant organisms | |
| Fisher et al. | A system for the quantitation of DNA using a microtiter plate-based hybridization and enzyme amplification technology | |
| Brewer et al. | A cellular single-stranded DNA-dependent ATPase associated with simian virus 40 chromatin. | |
| EP0401313B1 (en) | Macromolecular conjugate | |
| EP0543222A1 (en) | Method for detecting nucleic acids and relative diagnostic kit | |
| WO2000043546A9 (en) | Detection of drug resistant organisms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1A | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| SNR | Assignments of patents or rights arising from examined patent applications |
Owner name: SANGTEC MEDICAL AB |
|
| SNR | Assignments of patents or rights arising from examined patent applications |
Owner name: SANGTEC MOLECULAR DIAGNOSTICS AB |
|
| V1 | Lapsed because of non-payment of the annual fee |
Effective date: 20050701 |